Hypernatraemia Clinical Trial
Official title:
Hypernatraemia and Diuretics in Intensive Care Patients
Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce hypernatremia and shorten the time of hypernatremia, we investigate the effect of hydrochloorthiazide compared to a placebo
Status | Completed |
Enrollment | 50 |
Est. completion date | May 2015 |
Est. primary completion date | May 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - sodium > 142 Exclusion Criteria: - no informed consent |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Netherlands | Medical Centre Leeuwarden | Leeuwarden | Friesland |
Lead Sponsor | Collaborator |
---|---|
Medical Centre Leeuwarden |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | sodium level | a decrease of 5 mmol/L sodium in plama | 7 days | Yes |
Secondary | time hypernatraemia | decrease of duration high sodium level in plasma | 7 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01008644 -
Do Changes in Plasma Osmolality Influence Ventilation?
|
Phase 0 |